Lucira Health, Inc. (LHDX) Social Stream



Lucira Health, Inc. (LHDX): $6.98

0.94 (+15.56%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Lucira Health Inc (LHDX) Price Targets From Analysts

Use the tables below to see what analysts covering Lucira Health Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2 $9 $8 $8.5 $6.08 39.8%

The Trend in the Analyst Price Target


Over the past 128 days, LHDX's average price target has gone down $0.

LHDX reports an average of 50.56% for its upside potential over the past 27 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 2 9 8 8.5 7.68 10.68%
2021-09-19 2 9 8 8.5 7.88 7.87%
2021-09-18 2 9 8 8.5 7.88 7.87%
2021-09-09 2 9 8 8.5 8.54 -0.47%
2021-09-04 2 9 8 8.5 8.92 -4.71%
2021-08-28 2 9 8 8.5 9.57 -11.18%
2021-08-14 2 9 8 8.5 9.62 -11.64%
2021-08-07 2 9 8 8.5 9.88 -13.97%
2021-08-05 2 9 8 8.5 10.05 -15.42%
2021-08-01 2 9 8 8.5 9.81 -13.35%
2021-07-24 2 9 8 8.5 7.98 6.52%
2021-07-17 2 9 8 8.5 6.69 27.06%
2021-07-09 2 9 8 8.5 8.50 0%
2021-07-03 2 9 8 8.5 6.74 26.11%
2021-06-26 2 9 8 8.5 5.25 61.9%
2021-06-13 2 9 8 8.5 5.63 50.98%
2021-06-05 2 9 8 8.5 5.17 64.41%
2021-05-22 2 9 8 8.5 4.70 80.85%
2021-05-15 2 9 8 8.5 5.00 70%
2021-05-08 2 29 9 19.0 4.93 285.4%
2021-04-25 2 29 9 19.0 6.93 174.17%
2021-04-17 2 29 9 19.0 7.84 142.35%
2021-04-01 2 29 22 25.5 11.45 122.71%
2021-03-20 1 29 29 29.0 14.15 104.95%
2021-03-13 1 29 29 29.0 15.19 90.92%

LHDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.17 0 0 2 0 0 3

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LHDX as an investment opportunity.

  • LHDX has a higher average analyst price target than 15.57% of all US stocks.
  • LHDX has a higher number of analysts covering the stock than 16.91% of all US stocks.
  • Lucira Health Inc's variance in analysts' estimates is lower than 80.93% of Pharmaceutical Products stocks.
  • The upside potential (average analyst target price relative to current price) of LHDX is greater than 23.7% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, LMNL, APRE and CLVS are the three stocks most similar to Lucira Health Inc regarding the price target and analyst recommendation information presented here.

Is LHDX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4768 seconds.